Insulet (Nasdaq:PODD) shares took a hit after hours today on first-quarter results that came in mixed compared to the ...
Recall of Tandem Diabetes Care insulin pump app software is Class I, more than 200 injuries reported
t:slim X2 Insulin Pump from Tandem Diabetes Care with Abbott’s Freestyle Libre 2 Plus sensor integration now available in the ...
Embecta (Nasdaq:EMBC) shares got a massive boost today on first-quarter results that came in well ahead of the consensus ...
Medtronic (NYSE:MDT) issued an urgent field safety notice in Europe to warn of battery cap compatibility issues with the MiniMed 780G.
Smart Meter introduced a new version of its glucose meter with new features aimed at improving access to the diabetes ...
The FDA today granted integrated CGM (iCGM) designation to the Eversense continuous glucose monitoring system from Senseonics ...
Enable Injections announced that it expanded a collaboration with Roche to utilize its enFuse delivery technology in development programs.
In France, the prescription of Omnipod 5, except in particular medical situations, comes for only those whose consumption is less than or equal to 60 units of insulin per day. It remains unsuitable ...
Tandem Diabetes Care (Nasdaq:TNDM) shares got a massive boost today on first-quarter results that came in ahead of the ...
Abbott (NYSE: ABT) announced today that the FDA approved its Espirit everolimus-eluting resorbable scaffold system.
Abbott (NYSE:ABT) filed three patent lawsuits against SiBionics and its distribution partner in Europe, JUVE-Patent reports.
Xeris and Beta Bionics today announced an exclusive worldwide collaboration to develop a glucagon product for proprietary pump technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback